Operates a network of 47 hospitals in Thailand and Cambodia. Provides a wide range of medical services, including general and specialized treatments. Now — the numbers.
This is an established company with proven profits.
Average growth of 11% a year over the last 4 years. Every year shown ended in profit.
The gap is $310.7M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 18.5× for every dollar of annual profit — around what a business like this usually costs.
No analyst target is on record for this company.
The stock trades 37% below its peak. The market has trimmed its expectations for the company.
Over the last 4 years, sales grew about 11% a year on average.
The stock sits at $0.56. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
Since the drop from its peak, buyer appetite hasn’t come back.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.